Approval · Notice of Compliance 10433 · 2009
EES-200: Notice of Compliance 10433
Issued July 22, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10433
- Date
- July 22, 2009
- Company
- Amdipharm LimitedNorthwood, Dublin, Ireland
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antibiotic
Products in this notice
Medicinal ingredients
- ERYTHROMYCIN ETHYLSUCCINATE 40 MG per ML
- ERYTHROMYCIN ETHYLSUCCINATE 400 MG per 5ML